Suzanne Topalian, MD
Disclosures: Royalty-Bristol-Myers Squibb|Research Grants-Bristol-Myers Squibb-Principal_Investigator|Stock options and Research Grants-Compugen|Consulting Fee-Amgen|Receipt of Intellectual Property Rights/Patent Holder-Aduro|Consulting, stock options-Dragonfly Therapeutics|consulting, stock options-DNAtrix|consulting, stock-Ervaxx|Consulting and Stock-Five Prime Therapeutics|consulting, stock options-FLXBio|Stock options-Jounce Therapeutics|Consulting Fee-Janssen|Consulting Fee-MedImmune|Consulting Fee-Merck and Company, Inc.|consulting, stock-Potenza Therapeutics|Royalty-Potenza Therapeutics|Contracted Research-Potenza Therapeutics|Stock options-Potenza Therapeutics|Stock options-Tizona LLC|Consulting, stock, intellectual property licensed-WindMIL
No Bio Available.